Steve Schonfeld’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Steve Schonfeld’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,264	Closed	-$349K	–	1670
2020 Q1	$349K	Buy	+7,264	New	+$338K	0.02%	702
2019 Q3	–	Sell	-184,800	Closed	-$5.56M	–	1346
2019 Q2	$5.56M	Sell	184,800 -29,600	-14%	-$678K	0.2%	127
2019 Q1	$4.8M	Buy	+214,400	New	+$4.61M	0.17%	162

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Steve Schonfeld's RARX Position: Q2 2020 in Review

Steve Schonfeld sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 7,264 shares — an estimated $349K sold.

Steve Schonfeld first reported a position in RARX in Q1 2019 and held it in 3 quarters. The position peaked at $5.56M in Q2 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Steve Schonfeld reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Steve Schonfeld sold 7,264 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $349K.
Steve Schonfeld first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Steve Schonfeld's Ra Pharmaceuticals, Inc. Common Stock position peaked at $5.56M in Q2 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.